Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.26, expectations were $1.17.
Vinod Khosla said he measures AI industry health by API calls, not stock prices or Wall Street trends. Debate over an AI ...
In an AI-driven job market, degrees aren’t enough. CodeSignal’s university partnerships embed verified, AI-ready skills ...
A year after Katie Abraham was killed by an illegal immigrant, her father Joe faults Gov. JB Pritzker’s weak policies and ...
On this Special Report, India Today’s Anisha Mathur provides a detailed update on the Supreme Court's latest directions ...
Nearly two decades after the Supreme Court affirmed the right to choose a life partner, honour killings continue with ...
Wipro Limited ( WIT) Q3 2026 Earnings Call January 16, 2026 8:30 AM EST ...
Days before a scheduled foreclosure auction, the nonprofit St. Paul Downtown Development Corporation announced earlier this ...
Precigen, Inc. ( PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST ...
Kaitlyn Nguyen received a full-ride scholarship to Minnesota’s Carleton College through 2025 QuestBridge National College ...
In this report, a survivor recounts a harrowing assault inside a cab in Bengaluru and raises concerns over the lack of police ...
The University of Austin was supposed to be a bulwark against cancel culture. But those who dissented from rigid conservative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback